OBJECTIVES: Allogeneic blood transfusion for anemia correction before surgery has been independently associated with postoperative morbidity and mortality in multiple surgical fields. Blood transfusion has been identified as one of the most overused treatments in US hospitals and is associated with a significant health care expenditure. Our objective is to investigate the impact of preoperative Oral Posters blood transfusion on postoperative complications following laparoscopic hysterectomy done for benign indications. MATERIALS AND METHODS: This is a retrospective national database cohort study from the academic centers affiliated with the American College of Surgeons National Surgery Quality Improvement Program (ACS-NSQIP). Data from individuals who underwent laparoscopic hysterectomy for benign indications between 2012 and 2016 were collected for analysis. Patients were identified based on their CPT and ICD codes. Univariate analysis using ANOVA and chisquared tests were performed to evaluate associations between transfusion requirement and patient demographics and comorbidities. Binary logistic regression analysis was completed to determine independent associations of transfusion requirement with postoperative complications. RESULTS: A total of 96,579 patients who underwent laparoscopic hysterectomy for benign indications between 2012 and 2016 were collected for analysis. In total, 1,381 (1.4%) patients received a perioperative transfusion, while 95,198 (98.5%) did not. Patients receiving a perioperative transfusion were more likely to be nonwhite (p<0.001), and younger (p<0.001). They were also more likely to have multiple comorbidities such as anemia (p<0.001), diabetes (p¼0.018), renal failure requiring dialysis (p<0.001), a bleeding disorder (p<0.001). Using multivariate regression analyses, perioperative transfusion was found to be independently associated with multiple infectious comorbidities including organ space infection (OR ¼ 1.9; 95% CI ¼ 1.0, 3.7; p ¼ 0.032), total wound comorbidity (OR ¼ 2.0; 95% CI ¼ 1. 
OBJECTIVES:
To determine the oral morphine equivalents (OMEs) prescribed and refill rates following hysterectomy and hysteroscopy in the setting of statewide legal changes to opioid prescribing across two states. MATERIALS AND METHODS: Patients undergoing hysterectomy (including concomitant procedures for oncology and urogynecology cases) and hysteroscopy (diagnostic and operative) from January 2011 through July 2018 were identified using Current Procedural Terminology (CPT) procedure codes in our institution's databases in two affiliated hospitals (Arizona and Florida). Hysterectomy was chosen as the most invasive gynecologic procedure requiring the most postoperative narcotic medication, while hysteroscopy was chosen as the least invasive necessitating the fewest postoperative narcotics. Opioid prescriptions at time of discharge and refills within 30 days were identified and converted to OMEs. OMEs were calculated per quarter year. In Arizona, the Arizona Opioid Epidemic Act was passed in January 2018 and went into effect in April 2018; this limited prescriptions to 90 OMEs per day for five days. In Florida, House Bill 21 restricted prescribing of Schedule II medications to three days for acute pain or up to seven days when medically necessary. The law was signed in March 2018 and took effect in July 2018. Prior to these changes, there were a number of informal provider-led initiatives in both departments to reduce opioid prescribing given the media attention to the subject. Our study compares prescribed OMEs and refill rates before and after the first quarter in 2018. RESULTS: In Arizona, 2204 hysterectomies were performed during the study period; 1077 (49%) were vaginal, 1002 (45%) were laparoscopic/robotic, and 125 (6%) were abdominal. There were 1196 hysteroscopies. Median OMEs for all four procedure types were unchanged before and after 2018 (225). The overall opioid refill rate decreased, from 10% prior to 2018 versus 4% after 2018 (p value 0.0004). In Florida, there were 1459 hysterectomies; 380 (26%) vaginal, 936 (64%) laparoscopic/robotic, and 143 (10%) abdominal. There were 972 hysteroscopies. Overall median OMEs decreased from 245 prior to 2018 to 0 after 2018, p value <0.0001. The opioid refill rate decreased, from 8% prior to 2018 versus 4% after 2018 (p value 0.01). Figure 1 shows the OME trends by surgical procedure and hospital site over time. CONCLUSION: Many state governments have implemented laws to encourage safe prescribing of controlled substances. Our study demonstrates that the legislative changes sustained preexisting decreases in opioid prescribing in Florida but not in Arizona. In addition, significant reductions in opioid refills after 2018 were observed in both sites. Gynecologic surgeons must not only participate in safe prescribing practices, but also educate patients about pain control alternatives to further decrease opioid dependence and misuse.
